About this Research Topic
The escalating prevalence of infectious diseases, compounded by the rapid emergence of drug-resistant pathogens, underscores a critical need for novel therapeutic strategies. Traditional antimicrobial treatments are becoming less effective, necessitating the exploration of innovative pharmacological solutions to combat these global health threats. This urgency is amplified by the continuous evolution of both new and re-emerging infectious agents, posing significant challenges to public health systems worldwide.
This Research Topic aims to explore two promising fronts in the battle against infectious diseases: natural products and nanotechnology. Natural products, with their diverse and potent biological activities, have historically served as a foundational element in therapeutic development. By leveraging advanced ethnopharmacological practices and integrating cutting-edge screening technologies, there is tremendous potential to unlock novel anti-infective agents from natural sources. Additionally, the advent of nanotechnology offers transformative approaches to drug delivery, enhancing the efficacy and safety of treatments by optimizing pharmacokinetics and minimizing systemic toxicity. These nanoscale innovations are setting new paradigms for diagnosing, treating, and preventing infectious diseases.
To further advance these interdisciplinary approaches, this Research Topic will focus on:
•The integration of natural product research and nanotechnology in developing novel infectious disease therapies.
•Advances in nanoparticle delivery systems specifically tailored for natural antimicrobial compounds.
•Comprehensive reviews and original research on the synergistic effects of natural products and nanotechnological methods.
•Case studies and reports documenting the clinical applications and outcomes of these innovative treatments.
•Methods articles detailing new techniques for extracting and synthesizing bioactive natural compounds or designing targeted nanocarriers.
This initiative encourages submissions from various disciplines to foster cross-sectoral collaboration and catalyze breakthroughs in infectious disease pharmacology.
This Research Topic aims to explore two promising fronts in the battle against infectious diseases: natural products and nanotechnology. Natural products, with their diverse and potent biological activities, have historically served as a foundational element in therapeutic development. By leveraging advanced ethnopharmacological practices and integrating cutting-edge screening technologies, there is tremendous potential to unlock novel anti-infective agents from natural sources. Additionally, the advent of nanotechnology offers transformative approaches to drug delivery, enhancing the efficacy and safety of treatments by optimizing pharmacokinetics and minimizing systemic toxicity. These nanoscale innovations are setting new paradigms for diagnosing, treating, and preventing infectious diseases.
To further advance these interdisciplinary approaches, this Research Topic will focus on:
•The integration of natural product research and nanotechnology in developing novel infectious disease therapies.
•Advances in nanoparticle delivery systems specifically tailored for natural antimicrobial compounds.
•Comprehensive reviews and original research on the synergistic effects of natural products and nanotechnological methods.
•Case studies and reports documenting the clinical applications and outcomes of these innovative treatments.
•Methods articles detailing new techniques for extracting and synthesizing bioactive natural compounds or designing targeted nanocarriers.
This initiative encourages submissions from various disciplines to foster cross-sectoral collaboration and catalyze breakthroughs in infectious disease pharmacology.
Keywords: Infectious diseases, antimicrobial resistance, natural products, nanotechnology, drug delivery, targeted therapy, vaccine development, integrative therapy, pharmacological innovation.
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
